Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 106 AL 120

PUBMED

Tnfaip8 l1/Oxi-β binds to FBXW5, increasing autophagy through activation of TSC2 in a Parkinson's disease model.

Ha JY, Kim JS, Kang YH, Bok E, Kim YS, Son JH.

J Neurochem. 2014 May;129(3):527-38. doi: 10.1111/jnc.12643.

0

0

0

PUBMED

Creatine for Parkinson's disease.

Xiao Y, Luo M, Luo H, Wang J.

Cochrane Database Syst Rev. 2014 Jun 17;(6):CD009646. doi: 10.1002/14651858.CD009646.pub2. Review.

0

0

0

PUBMED

Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.

Hong JY, Sunwoo MK, Chung SJ, Ham JH, Lee JE, Sohn YH, Lee PH.

Neurobiol Aging. 2014 Jul;35(7):1739-43. doi: 10.1016/j.neurobiolaging.2013.11.017.

0

0

0

PUBMED

Adapting the Sniffin' Sticks olfactory test to diagnose Parkinson's disease in Estonia.

Antsov E, Silveira-Moriyama L, Kilk S, Kadastik-Eerme L, Toomsoo T, Lees A, Taba P.

Parkinsonism Relat Disord. 2014 Aug;20(8):830-3. doi: 10.1016/j.parkreldis.2014.04.012.

0

0

0

PUBMED

Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.

Jost WH, Friede M, Schnitker J.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3349. No abstract available.

0

0

0

PUBMED

Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort.

Okun MS, Wu SS, Jennings D, Marek K, Rodriguez RL, Fernandez HH.

J Clin Mov Disord. 2014 Nov 26;1:8. doi: 10.1186/2054-7072-1-8.

0

0

0

PUBMED

Comparing the effects of hydrotherapy and land-based therapy on balance in patients with Parkinson's disease: a randomized controlled pilot study.

Volpe D, Giantin MG, Maestri R, Frazzitta G.

Clin Rehabil. 2014 Dec;28(12):1210-7. doi: 10.1177/0269215514536060.

0

0

0

PUBMED

Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.

Kuo C, Tjaden K, Sussman JE.

J Commun Disord. 2014 Nov-Dec;52:156-69. doi: 10.1016/j.jcomdis.2014.09.002.

0

0

0

PUBMED

Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.

AlDakheel A, Kalia LV, Lang AE.

Neurotherapeutics. 2014 Jan;11(1):6-23. doi: 10.1007/s13311-013-0218-1. Review.

0

0

0

PUBMED

Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.

Migliore MM, Ortiz R, Dye S, Campbell RB, Amiji MM, Waszczak BL.

Neuroscience. 2014 Aug 22;274:11-23. doi: 10.1016/j.neuroscience.2014.05.019.

0

0

0

PUBMED

Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Löhle M, Ramberg CJ, Reichmann H, Schapira AH.

Drugs. 2014 Apr;74(6):645-57. doi: 10.1007/s40265-014-0209-5. Review.

0

0

0

PUBMED

[The study of telomere length in patients with Parkinson's disease].

Koliada AK, Vaĭserman AM, Krasnenkov DS, Karaban' IN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(8):58-61. Russian.

0

0

0

PUBMED

Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.

Aono M, Iga J, Ueno S, Agawa M, Tsuda T, Ohmori T.

J Clin Neurosci. 2014 Sep;21(9):1595-8. doi: 10.1016/j.jocn.2013.12.020.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy